A White Paper, from Brian McMillan
The Journey of Bravado Pharmaceutcals and the Development of CoVer Nasal Antibody Drops
Bravado invites you to read a white paper recently written by our founder, Brian McMillan, for Pharmaceutical Technology regarding development of "Cover Nasal Antibody Drops" during the CV-19 pandemic.
Bravado Pharmaceuticals developed this product in conjunction with Stanford University and SPARKGLOBAL.
The program was led by Professor Daria Mochly Rosen of Stanford and SPARKGLOBAL.
See our White Paper HERE